News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FLETCHER MARK
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2016 |
4
| FLETCHER MARK (President & CEO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Exercised 4,447,111 options to buy
@ $0.001, valued at
$4.4k
|
|
| 02/12/2016 |
4
| FLETCHER MARK (President & CEO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Exercised 1,457,195 options to buy
@ $0.001, valued at
$1.5k
Exercised 5,143,787 options to buy
@ $0.001, valued at
$5.1k
Exercised 1,587,300 options to buy
@ $0.001, valued at
$1.6k
Exercised 4,447,111 options to buy
@ $0.001, valued at
$4.4k
|
|
| 10/08/2014 |
4
| FLETCHER MARK (President & CEO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Exercised 470,726 options to buy
@ $0.001, valued at
$470.7 |
|
| 11/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2013 |
4
| FLETCHER MARK (President & CEO) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 1,587,300 options to buy
@ $0.001, valued at
$1.6k
|
|
| 04/25/2011 |
4
| FLETCHER MARK (See Remarks) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Granted 1,500,000 options to buy
@ $0.282, valued at
$423k
|
|
| 04/07/2011 |
4
| FLETCHER MARK (See Remarks) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Bought 20,000 shares
@ $0.239, valued at
$4.8k
|
|
| 03/10/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2010 |
4
| FLETCHER MARK (EVP & General Counsel) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Bought 8,700 shares
@ $0.52, valued at
$4.5k
|
|
| 11/16/2009 |
4
| FLETCHER MARK (EVP & General Counsel) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP|
Txns:
| Bought 10,000 shares
@ $0.49, valued at
$4.9k
|
|
| 01/12/2009 |
4
| FLETCHER MARK (EVP & General Counsel) has filed a Form 4 on GENEREX BIOTECHNOLOGY CORP |
|
|